Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Knoll/Hokuriku Seiyaku

Executive Summary

Knoll/Hokuriku Seiyaku: Knoll completes acquisition of 51% of the Japanese firm April 8, purchasing 19 mil. shares of Hokuriku stock at $13.46 (1,450 yen) per share for a total price of $255.5 mil. The shares purchased include the 12.25% stake owned by Searle. Knoll intends to keep Hokuriku's management in place for the time being but will integrate the company with Knoll Japan in the medium term. Hokuriku's major product categories include generics, antibiotics, peripheral nervous system and respiratory disease...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS027987

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel